FIELD: medicine.
SUBSTANCE: with underlying antiviral therapy, blood is exposed intravenously to wave length 365 nm first, emission power 2 mWt, exposure 2 minutes. On the next day - at wave length 530 nm, emission power 2 mWt, exposure 8 minutes. There are 15 sessions of intravenous laser blood irradiation prescribed.
EFFECT: terminated reactivation of urogenital cytomegaloviral infection, reduced length of the following recurrent cases, prolongs an intercurrent period and promotes the clinical course of the viral infectious process transformed into a persistence ensured by stimulation of an inadequate immune response, normalises the interferon status and suppression of the hyperactive processes.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH SCLEROTIC VULVAR LICHEN | 2016 |
|
RU2620683C1 |
| METHOD OF INCREASING CLINICAL IMMUNE EFFICIENCY OF GENITAL HERPES THERAPY USING INTRAVASCULAR BLOOD LASER EXPOSURE | 2015 |
|
RU2602304C1 |
| METHOD OF LOCAL IMMUNOCORRECTION OF FEMALE INFECTIOUS-INFLAMMATORY UROGENITAL DISEASES CAUSED BY SEXUALLY-TRANSMITTED MICROORGANISMS | 2009 |
|
RU2455037C2 |
| METHOD FOR LASER THERAPY OF PATIENTS WITH ATOPIC DERMATITIS | 2014 |
|
RU2562317C1 |
| METHOD OF TREATING URINOGENITAL INFECTIONS IN PREGNANT WOMEN | 2008 |
|
RU2377032C1 |
| METHOD OF LASER THERAPY OF PATIENTS WITH TROPHIC ULCERS | 2015 |
|
RU2604399C1 |
| METHOD FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASE OF UTERUS CERVIX AND VAGINA | 2004 |
|
RU2278672C2 |
| USING COMPLEX OF ANTIOXIDANT VITAMINS AND AMINO ACIDS AS ADDITION TO STANDARD THERAPEUTIC APPROACHES AND METHOD OF TREATING PAPILLOMAVIRUS-ASSOCIATED PRE-MALIGNANT UTERINE DISEASES AND PREVENTING CANCER FORMATION ACCOMPANYING PAPILLOMAVIRUS INFECTION | 2013 |
|
RU2537233C2 |
| METHOD OF TREATING CYTOMEGALOVIRAL INFECTION IN PREGNANT WOMEN | 2019 |
|
RU2729786C1 |
| METHOD FOR RESTORING AND KEEPING FAMILY HEALTH | 2002 |
|
RU2230558C2 |
